HBM9378/SKB378 is designed to inhibit the TSLP-mediated signaling pathway, aiming to reduce airway inflammation and improve lung function in patients with COPD. "This regulatory clearance from the ...
HBM9378/SKB378 is designed to inhibit the TSLP-mediated signalling pathway, aiming to reduce airway inflammation and improve lung function in patients with COPD. "This regulatory clearance from the ...
"We are delighted to partner with Windward Bio to advance the development of HBM9378/SKB378, a promising TSLP-targeted fully human antibody with significant potential to address immunological diseases ...
HBM9378/SKB378 is designed to inhibit the TSLP-mediated signaling pathway, aiming to reduce airway inflammation and improve lung function in patients with COPD. "This regulatory clearance from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback